Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 …
A Widmark, A Gunnlaugsson, L Beckman… - The Lancet, 2019 - thelancet.com
… The outcomes of the HYPO-RT-PC trial are specifically relevant for patients with … Our
results support the use of image-guided ultra-hypofractionated radiotherapy for prostate cancer. …
results support the use of image-guided ultra-hypofractionated radiotherapy for prostate cancer. …
Prostate cancer radiation therapy: what do clinicians have to know?
BGL Vanneste, EJ Van Limbergen… - BioMed research …, 2016 - Wiley Online Library
… Radiotherapy (RT) for prostate cancer (PC) has steadily evolved over the last decades, with
… -risk PC. Examples of improved RT techniques are image-guided RT, intensity-modulated RT…
… -risk PC. Examples of improved RT techniques are image-guided RT, intensity-modulated RT…
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised …
P Fransson, P Nilsson, A Gunnlaugsson… - The Lancet …, 2021 - thelancet.com
… This analysis of patient-reported QOL from the HYPO-RT-PC trial shows the long-term …
prostate cancer. This study adds to the growing evidence for ultra-hypofractionated radiotherapy …
prostate cancer. This study adds to the growing evidence for ultra-hypofractionated radiotherapy …
Radical prostatectomy or radiotherapy in high-risk prostate cancer: a systematic review and metaanalysis
F Petrelli, I Vavassori, A Coinu, K Borgonovo… - … genitourinary cancer, 2014 - Elsevier
… -risk prostate cancer (PC), but it has never been compared with external beam radiotherapy
(RT), … To compare the outcomes of patients treated with surgery versus RT, we performed a …
(RT), … To compare the outcomes of patients treated with surgery versus RT, we performed a …
Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation
S Hummel, EL Simpson, P Hemingway… - Health Technol …, 2010 - emerald.com
… Prostate cancer (PC) is the most common cancer in men in the UK. Radiotherapy (RT) is
a recognised treatment for PC and high-dose conformal radiotherapy (CRT) is the …
a recognised treatment for PC and high-dose conformal radiotherapy (CRT) is the …
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial
DP Dearnaley, MR Sydes, JD Graham, EG Aird… - The lancet …, 2007 - thelancet.com
… -effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. …
of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer. …
of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer. …
… conventionally fractionated radiotherapy for intermediate risk prostate cancer: early toxicity results from the Scandinavian randomized phase III trial “HYPO-RT-PC”
A Widmark, A Gunnlaugsson, L Beckman… - International Journal of …, 2016 - redjournal.org
… The HYPO-RT-PC non-inferiority trial accrued 1200 intermediate risk prostate cancer
patients (T1c-T3a, PSA ≤20, with one or two of the following risk factors: T3a or Gleason ≥7 or …
patients (T1c-T3a, PSA ≤20, with one or two of the following risk factors: T3a or Gleason ≥7 or …
[PDF][PDF] Longitudinal study of quality of life in patients with localized prostate cancer undergoing radiotherapy.
U Monga, AJ Kerrigan, J Thornhy… - Journal of …, 2005 - researchgate.net
… Therapy—General (FACTG) and a 12-item disease-specific subscale for prostate cancer
called “Prostate Cancer Specific” (PCS) [21]. The FACT-G instrument has five subscales …
called “Prostate Cancer Specific” (PCS) [21]. The FACT-G instrument has five subscales …
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study
L Triggiani, F Alongi, M Buglione, B Detti… - … journal of cancer, 2017 - nature.com
… The treatment of patients with metastatic prostate cancer (PC) is rapidly evolving. Androgen
deprivation therapy (ADT) with analogues or antagonist of Lh-Rh remains the standard of …
deprivation therapy (ADT) with analogues or antagonist of Lh-Rh remains the standard of …
Androgen regulation of micro‐RNAs in prostate cancer
KK Waltering, KP Porkka, SE Jalava, A Urbanucci… - … Prostate, 2011 - Wiley Online Library
… -castrated prostate cancer (PC) xenograft pairs, as well as clinical specimens of untreated
(PC) … The expression of miRNAs was analyzed by microarrays and quantitative RT-PCR (Q-RT-…
(PC) … The expression of miRNAs was analyzed by microarrays and quantitative RT-PCR (Q-RT-…
相关搜索
- intermediate risk prostate cancer rt pc
- instrument validation prostate cancer with radiotherapy
- localised prostate cancer radiotherapy in comparison
- radical prostatectomy prostate cancer
- radiation therapy prostate cancer
- conventionally fractionated radiotherapy prostate cancer
- prostate cancer patients
- prostate cancer cells
- stereotactic body radiotherapy prostate cancer
- controlled trial prostate cancer
- high dose prostate cancer
- dose escalation prostate cancer
- systematic review prostate cancer
- meta analysis prostate cancer
- external beam radiotherapy prostate cancer
- quality of life prostate cancer